Corporate Corruption News Articles

Excerpts of key news articles on

Below are key excerpts of revealing news articles on corporate corruption from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

Note: Explore our full index to revealing excerpts of key major media news articles on dozens of engaging topics. And read excerpts from 20 of the most revealing news articles ever published.

The chairman and CEO of Pfizer, Albert Bourla, sold $5.6 million worth of stock in the pharmaceutical company on Monday. The sale took place on the same day Pfizer announced that its experimental coronavirus vaccine candidate was found to be more than 90% effective. Bourla's sale of Pfizer stock was part of a trading plan set months in advance. Known as 10b5-1 plans, they essentially put stock trades on autopilot. Executives are supposed to adopt these plans only when they are not in possession of inside information that can affect a company's stock price. On Aug. 19, Bourla implemented his stock-trading plan. The next day, Aug. 20, Pfizer issued a press release ... confirming that Pfizer and its German partner, BioNTech, were "on track to seek regulatory review" for its vaccine candidate. Daniel Taylor, an expert in insider trading ... told NPR that the close timing between the adoption of Bourla's stock plan and the press release looked "very suspicious." "It's wholly inappropriate for executives at pharmaceutical companies to be implementing or modifying 10b5-1 plans the business day before they announce data or results from drug trials," Taylor said. The stock sales by Pfizer's CEO brought to mind similar concerns with another coronavirus vaccine-maker, Moderna. Multiple executives at Moderna adopted or modified their stock-trading plans just before key announcements about the company's vaccine. Those executives have sold tens of millions of dollars in Moderna stock.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and Big Pharma profiteering from reliable major media sources.

Moderna CEO StÄ‚©phane Bancel more than tripled the number of his company shares to be sold through an executive stock plan that was changed just days after the biotech in May announced positive early results for its coronavirus vaccine. Moderna's shares spiked on the May news, rising 30% in just one day. After seeking the executive stock plan change in May, Bancel sold more than 72,000 Moderna shares in the first 16 days of July, generating nearly $4.8 million for the executive. That was more than triple the 22,000 shares he had previously scheduled to sell during the same period through the company's executive trading plan. Another top Moderna executive, President Stephen Hoge, also had his pre-programmed executive trading plan reset around the same time. The change allowed him to sell $1.9 million worth of Moderna stock in the first two weeks of July. The executives' ... sales were made through what are known as 10b5-1 stock plans. These arrangements must be set up or amended at least 30 days before any transactions are executed; they are commonly used at publicly traded companies to help shield executives from potential claims of insider trading. The fact that the plans were changed during the pandemic as news was emerging about the company's closely watched coronavirus vaccine raises new questions about how Moderna executives have pocketed millions of dollars in recent months.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and Big Pharma profiteering from reliable major media sources.

Bayer will pay more than $10 billion to resolve thousands of lawsuits regarding claims that its Roundup herbicide causes cancer, the company announced. Monsanto, bought by Bayer in 2018, lost a lawsuit that same year brought by a school groundskeeper who claimed its weedkiller had caused his non-Hodgkin's lymphoma. Since then, thousands of U.S. lawsuits have been filed against the company. The settlement, however, does not contain an admission of wrongdoing or liability. Bayer will pay $8.8 billion to $9.6 billion to settle existing lawsuits and then another $1.25 billion that will cover any potential litigation in the future. Lawsuits allege that Monsanto ignored warnings that its herbicide contained potentially cancer causing chemicals, then concealed the threat to consumers. A jury awarded California groundskeeper Dewayne Johnson nearly $290 million in damages in August 2018 after they found Monsanto failed to warn Johnson and other consumers about the risks posed by its weed-killing products. A judge upheld the decision upon appeal, but lowered the damages to $78 million due to what she considered an overreach in punitive damages decided by the jury. And last year, a California jury awarded a husband and wife more than $2 billion in damages in a suit that claimed Roundup caused their illness. German pharmaceuticals and chemical giant Bayer bought Monsanto in 2018 just months before Johnson won his suit against the company. Bayer eliminated the Monsanto name, but maintained the brands.

Note: The negative health impacts of Roundup are well known. Yet the EPA continues to use industry studies to declare Roundup safe while ignoring independent scientists. For more along these lines, see concise summaries of deeply revealing news articles on health from reliable major media sources.

The COVID-19 pandemic is far from a great equalizer. In the same month that 22 million Americans lost their jobs, the American billionaire class's total wealth increased about 10%–or $282 billion more than it was at the beginning of March. They now have a combined net worth of $3.229 trillion. The initial stock market crash may have dented some net worths at first–for instance, that of Jeff Bezos, which dropped down to a mere $105 billion on March 12. But his riches have rebounded: As of April 15, his net worth has increased by $25 billion. These "pandemic profiteers," as a new report from the Institute for Policy Studies, a progressive think tank, calls them, is just one piece of the wealth inequality puzzle in America. In the background is the fact that since 1980, the taxes paid by billionaires, measured as a percentage of their wealth, dropped 79%. "We're reading about benevolent billionaires sharing .0001% of their wealth with their fellow humans in this crisis, but in fact they've been rigging the tax rules to reduce their taxes for decades–money that could have been spent building a better public health infrastructure," says Chuck Collins [of] the Institute for Policy Studies and coauthor of the new report, titled "Billionaire Bonanza 2020: Wealth Windfalls, Tumbling Taxes, and Pandemic Profiteers." Another key finding of the report is that after the 2008 financial crisis, it took less than 30 months for billionaire wealth to return to its pre-meltdown levels. That wealth then quickly exceeded pre-2008 levels. But as of 2019, the middle class in America has not even yet recovered to the level of its 2007 net worth.

Note: This New York Post article shows how 43,000 millionaires in the U.S. will receive a "stimulus" gift averaging $1.6 million each. At the same time, this Reuters article claims that the coronavirus lockdown could plunge half a billion worldwide into poverty. And this BBC article warns of potential massive famines. So who is this lockdown really serving? For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.

Joi Ito, the director of the Media Lab at MIT, resigned Saturday and the university is calling for an independent investigation following explosive allegations that he and at least one other person at the lab made efforts to make sure Jeffrey Epstein's name was not associated with donations he made or helped solicit. Internal communications and documents obtained by CNN - first reported by the New Yorker - show Epstein was integral to incoming donations from major donors, including $2 million from Bill Gates and at least $5 million from Leon Black, the founder of private equity firm Apollo Global Management. Internal email exchanges show Ito was in direct contact with Epstein about the late financier's donations, which documents show at one point were earmarked for a research scientist. As discussions continued about the funding for the researcher, the Director of Development and Strategy, Peter Cohen, sent an email to an undisclosed recipient, saying "Jeffrey money, needs to be anonymous." Internal communications dating back to 2014 include several references to Epstein being allowed to make small donations anonymously. The communications show that Epstein helped as an intermediary on high-dollar proposals. In October of 2014 Ito sent an email stating, "This is a $2M gift from Bill Gates directed by Jeffrey Epstein." His director of Development and Strategy - Cohen - responds "Great! For gift recording purposes, we will not be mentioning Jeffreys name as the impetus for this gift."

Note: For more along these lines, see concise summaries of deeply revealing news articles on Jeffrey Epstein from reliable major media sources.

The origin, evolution and astonishing scale of America’s catastrophic opioid epidemic just got a lot clearer. The drug industry - the pill manufacturers, wholesalers and retailers - found it profitable to flood some of the most vulnerable communities in America with billions of painkillers. They continued to move their product, and the medical community and government agencies failed to take effective action, even when it became apparent that these pills were fueling addiction and overdoses and were getting diverted to the streets. This has been broadly known for years, but this past week, the more precise details became public for the first time. The revelatory data comes from the Drug Enforcement Administration and its Automation of Reports and Consolidated Orders System (ARCOS). “This really shows a relationship between the manufacturers and the distributors: They were all in it together,” said Jim Geldhof, a retired DEA employee. “We’re seeing a lot of internal stuff that basically confirms ... that it was all about greed, and all about money.” The data shows a trend in pill distribution that, according to the lawsuit plaintiffs, can’t be passed off as reasonable therapeutic medical treatment. The industry shipped 76 billion oxycodone and hydrocodone pills across the country from 2006 through 2012, the period covered by the ARCOS data released this past week. These pills didn’t flow in a steady stream but were more like a flash flood, spiking from 8.4 billion in 2006 to 12.6 billion in 2012.

Note: For more along these lines, see concise summaries of deeply revealing news articles on pharmaceutical industry corruption from reliable major media sources.

A team of researchers inside Pfizer made a startling find in 2015: The company’s blockbuster rheumatoid arthritis therapy Enbrel, a powerful anti-inflammatory drug, appeared to reduce the risk of Alzheimer’s disease by 64 percent. The results were from an analysis of hundreds of thousands of insurance claims. Verifying that the drug would actually have that effect in people would require a costly clinical trial - and after several years of internal discussion, Pfizer opted against further investigation and chose not to make the data public, the company confirmed. Researchers in the company’s division of inflammation and immunology urged Pfizer to conduct a clinical trial on thousands of patients, which they estimated would cost $80 million ... according to an internal company document obtained by The Washington Post. Pfizer’s deliberations, which previously have not been disclosed, offer a rare window into the frustrating search for Alzheimer’s treatments inside one of the world’s largest drug companies. Pfizer did share the data privately with at least one prominent scientist, but outside researchers contacted by The Post believe Pfizer also should at least have published its data, making the findings broadly available to researchers. “Of course they should. Why not?” said Rudolph E. Tanzi, a leading Alzheimer’s researcher and professor at Harvard Medical School. “It would benefit the scientific community to have that data out there,” said Keenan Walker, an assistant professor of medicine at Johns Hopkins.

Note: For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.

Purdue Pharma, the drug manufacturer that kickstarted the US opioid epidemic, corruptly influenced the World Health Organization in order to boost painkiller sales across the globe, according to a report by members of Congress. An investigation by Katherine Clark and Hal Rogers, who represent districts in Massachusetts and Kentucky hard hit by the US opioid epidemic, accuses Purdue of replicating its false marketing claims about the safety and effectiveness of opioids to change WHO prescribing guidelines in an attempt to expand foreign markets for its drugs. “The web of influence we uncovered paints a picture of a public health organization that has been corrupted by the opioid industry,” said Clark. “The WHO appears to be lending the opioid industry its voice and credibility, and as a result, a trusted public health organization is trafficking dangerous misinformation that could lead to a global opioid epidemic.” The report ... accuses Purdue of using pharma-funded organizations and specialists to influence the writing of WHO policy to encourage much wider prescribing of addictive high-strength opioids across the globe. It said that, as a result, “WHO guidelines are serving as marketing materials for Purdue”. [The] report alleges two WHO guidelines ... “contain dangerously misleading and, in some instances, outright false claims about the safety and efficacy of prescription opioids”. “Alarmingly, these guidelines mirror Purdue’s marketing strategies to increase prescriptions and expand sales,” the report found.

Note: Many doctors also profited from excessive prescribing of dangerous opioids. And according to a former DEA agent, Congress helped drug companies fuel the opioid epidemic. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.

The Food and Drug Administration is under pressure from the Trump administration to approve drugs faster, but researchers at the Yale School of Medicine found that nearly a third of those approved from 2001 through 2010 had major safety issues years after the medications were made widely available to patients. Seventy-one of the 222 drugs approved in the first decade of the millennium were withdrawn, required a "black box" warning on side effects or warranted a safety announcement about new risks, Dr. Joseph Ross ... and colleagues reported in JAMA. The Yale researchers' previous studies concluded that the FDA approves drugs faster than its counterpart agency in Europe does and that the majority of pivotal trials in drug approvals involved fewer than 1,000 patients and lasted six months or less. It took a median of 4.2 years after the drugs were approved for these safety concerns to come to light, the study found, and issues were more common among psychiatric drugs, biologic drugs, drugs that were granted "accelerated approval" and drugs that were approved near the regulatory deadline for approval. "All too often, patients and clinicians mistakenly view FDA approval as [an] indication that a product is fully safe and effective," [Dr. Caleb Alexander] says. "Nothing could be further from the truth. We learn tremendous amounts about a product only once it's on the market and only after use among a broad population."

Note: For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption and health from reliable major media sources.

Samsung is warning customers about discussing personal information in front of their smart television set. The warning applies to TV viewers who control their Samsung Smart TV using its voice activation feature. When the feature is active, such TV sets "listen" to what is said and may share what they hear with Samsung or third parties, it said. Privacy campaigners said the technology smacked of the telescreens, in George Orwell's 1984, which spied on citizens. The warning came to light via a story in ... the Daily Beast which published an excerpt of a section of Samsung's privacy policy for its net-connected Smart TV sets. These record what is said when a button on a remote control is pressed. The policy explains that the TV set will be listening to people in the same room to try to spot when commands or queries are issued via the remote. It goes on to say: "If your spoken words include personal or other sensitive information, that information will be among the data captured and transmitted to a third party." Corynne McSherry, an intellectual property lawyer for the Electronic Frontier Foundation, [said] that the third party was probably the company providing speech-to-text conversion for Samsung. She added: "If I were the customer, I might like to know who that third party was, and I'd definitely like to know whether my words were being transmitted in a secure form." The third party handling the translation from speech to text is a firm called Nuance, which specialises in voice recognition, Samsung has confirmed to the BBC.

Note: Read more about Samsung's privacy issues in this 2013 Houston Chronicle article. For more along these lines, see concise summaries of deeply revealing news articles on the disappearance of privacy from reliable major media sources.

California will begin making its own low-cost insulin in an effort to make the essential diabetes treatment more affordable, Gov. Gavin Newsom announced on Thursday. "Nothing epitomizes market failures more than the cost of insulin," the governor said in a video posted on Twitter, "Many Americans experience out-of-pocket costs anywhere from three hundred to five hundred dollars per month for this life-saving drug." With a budget of $100 million, California plans to "contract and make our own insulin at a cheaper price, close to at cost, and to make it available to all," Newsom said. It's unclear exactly how inexpensive California's insulin will be or when the low-cost drugs will be available. Insulin in the U.S. costs almost $100 per unit, on average. That's nearly four times the price in Chile, which has the second-highest prices among the 34 countries analyzed by the nonprofit Rand Corporation, at less than $25 per unit. Currently, four in five Americans in need of insulin have incurred thousands of dollars in credit card debt to pay for the medication, according to a recent survey commissioned by health care organization CharityRx. The average debt among all survey participants was $9,000. California's program will allot $50 million toward the development of cheaper insulin products and $50 million on an in-state insulin manufacturing facility, Newsom said, adding that the facility "will provide new, high-paying jobs and a stronger supply chain for the drugs."

Note: The unethical corruption of big Pharma is so clearly seen in the ridiculously inflated prices of drugs in the US compared to other countries. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma profiteering from reliable major media sources.

The prices of new drugs in the U.S. have climbed for more than a decade, a study published Tuesday finds. According to a research letter in the Journal of the American Medical Association, the launch prices of new brand-name drugs increased by nearly 11 percent every year from 2008 through 2021. "These prices are increasing far out of proportion to other health care services," said the lead author, Dr. Benjamin Rome. Rome, and his colleagues observed price increases for all types of drugs, including cancer drugs, non-cancer drugs, pills and injections, he said. "Ultimately," he said, "all health care costs are borne by consumers – either direct out-of-pocket costs, higher premiums or taxes in the case of public health insurance." He added, "Insurance companies can also require prior authorization for expensive new drugs or not cover the drugs at all." The researchers calculated the negotiable sticker prices for new drugs on the market, or the net price. Such prices, which were adjusted for inflation, were calculated in light of rebates many drugmakers offer for the drugs. The researchers limited their scope to drugs sold by public companies; the net price averages included nearly 400 new drugs in total. Median drug prices for a year's supply increased from $2,115 in 2008 to more than $180,000 in 2021. The greatest increases were for cancer drugs and therapies used to treat rare diseases. In 2008, 9 percent of drugs cost $150,000 or more a year, compared to 47 percent in 2021.

Note: For a more detailed and eye-opening analysis, see this article. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma profiteering from reliable major media sources.

An unprecedented spree of policy changes and carveouts aimed at protecting Ukrainian civilians from Facebook's censorship systems has earned praise from human rights groups. But a new open letter addressed to Facebook and its social media rivals questions why these companies seem to care far more about some attempts to resist foreign invasion than others. In response to the Russian invasion of Ukraine, Meta Platforms, which owns Facebook and Instagram, rapidly changed its typically strict speech rules in order to exempt a variety of posts that would have otherwise been deleted for violating the company's prohibition against hate speech and violent incitement. The rule change ... included a rare dispensation to call for the death of Russian President Vladimir Putin, use dehumanizing language against Russian soldiers, and praise the notorious Azov Battalion of the Ukrainian National Guard, previously banned from the platform due to its neo-Nazi ideology. In a statement signed by 31 civil society and human rights groups ... criticism is directed squarely at American internet titans like Facebook. "We call for ... equal and consistent application of policies to uphold the rights of users worldwide," reads the letter. "Once platforms began to take action in Ukraine, they took extraordinary steps that they have been unwilling to take elsewhere. From the Syrian conflict to the genocide of the Rohingya in Myanmar, other crisis situations have not received the same amount of support."

Note: For more along these lines, see concise summaries of deeply revealing news articles on media manipulation from reliable sources.

Snopes, which has long presented itself as the internet's premier fact-checking resource, has retracted 60 articles after a BuzzFeed News investigation found that the site's co-founder plagiarized from news outlets as part of a strategy intended to scoop up web traffic. "As you can imagine, our staff are gutted and appalled by this," Vinny Green, the Snopes chief operating officer, said. He said the Snopes editorial team was conducting a review to understand just how many articles written by David Mikkelson, the site's co-founder and chief executive, featured content plagiarized from other news sites. As of Friday afternoon, the team had found 60, he said. By Friday morning, dozens of articles had been removed from the site, with pages that formerly featured those articles now showing the word "retracted" and an explanation that "some or all of its content was taken from other sources without proper attribution." Mr. Mikkelson, who owns 50 percent of Snopes Media Group, will continue to be Snopes's chief executive, but his ability to publish articles has been revoked, Mr. Green said. In a statement, Mr. Mikkelson acknowledged he had engaged in "multiple serious copyright violations of content that Snopes didn't have rights to use." From 2015 to 2019 – under the Snopes byline, his own name and another pseudonym – Mr. Mikkelson published dozens of articles that included language that appeared to have been copied directly from The New York Times, CNN, NBC News, the BBC and other news sources.

Note: There are many serious questions about the biases of Snopes and some of their unscrupulous tactics, as is covered in this Forbes article. For more along these lines, see concise summaries of deeply revealing news articles on media corruption from reliable sources.

Robert Mazur was a federal agent. He infiltrated Pablo Escobar's Colombian drug cartel for two years in the mid-1980s by pretending to be Robert Musella, a money-laundering, mob-connected businessman. "My role was to come across to the cartel as a credible money launderer," Mazur said. As an undercover operative, he was working with the Bank of Credit and Commerce International, a Luxembourg-based bank with branches in more than 70 countries, in order to launder the cartel's money. BCCI was known to have accounts of drug operatives, terrorists, dirty bankers and others who want to hide money. At one point, he was out at a social event in Miami with a senior bank officer at BCCI who asked him point blank, "You know who the biggest money launderer in the world is? It's the Federal Reserve, of course." That sounds like a crazy allegation, but Mazur said the banker connected the dots for him: In Colombia, it's illegal for anyone to have a U.S. dollar account. But at the state-run Bank of the Republic there is a window they call the "sinister window" or the "anonymous window." There, you can trade in as much U.S. currency as you want. The central bank exchanges it for Colombian pesos at a high rate immediately. Mazur recalls the banker asking: "What do you think happens with that cash? It gets put on pallets, they shrink-wrap it and they're sending hundreds of millions of dollars back to the Federal Reserve. Why didn't anyone ... ask where this money was coming from?"

Note: For more along these lines, see concise summaries of deeply revealing news articles on financial system corruption from reliable major media sources.

The offices of the Carlyle Group are on Pennsylvania Avenue in Washington DC, midway between the White House and the Capitol building. The address reflects Carlyle's position at the very centre of the Washington establishment. For 14 years now, with almost no publicity, the company has been signing up an impressive list of former politicians - including the first President Bush and his secretary of state, James Baker; John Major; one-time World Bank treasurer Afsaneh Masheyekhi and several south-east Asian powerbrokers - and using their contacts and influence to promote the group. But since the start of the "war on terrorism", the firm - unofficially valued at $3.5bn - has ... become the thread which indirectly links American military policy in Afghanistan to the personal financial fortunes of its celebrity employees, not least the current president's father. Among the firm's multi-million-dollar investors were members of the family of Osama bin Laden. "It should be a deep cause for concern that a closely held company like Carlyle can simultaneously have directors and advisers that are doing business and making money and also advising the president of the United States," says Peter Eisner, managing director of the Center for Public Integrity. "The problem comes when private business and public policy blend together. What hat is former president Bush wearing when he tells Crown Prince Abdullah not to worry about US policy in the Middle East?"

Note: Watch a 45-minute video on this subject titled Exposed: The Carlyle Group. For more along these lines, see concise summaries of deeply revealing news articles on government corruption from reliable major media sources.

A spritz of perfume may feel like such a minor chemical exposure compared to the pollutants elsewhere in our environment – microplastics, air pollution, PFAS. But scientists and clinicians are increasingly raising alarm over a group of chemicals used in many personal care products: phthalates. Phthalates – found in popular perfumes, nail polishes and hair care products – have been linked to numerous adverse health outcomes: insulin resistance, cardiovascular disease and impaired neurodevelopment. A study published in JAMA Network Open found that higher urinary concentrations of phthalates from personal care products was linked to a 25 percent increased risk of hyperactivity problems among adolescents. Another study of the same cohort found that increased phthalate exposure was also associated with poorer performance in math. The concerns about childhood exposure to phthalates are high enough that in the United States, certain types of the chemical are banned in children's toys and items such as pacifiers and baby bottles. For Andrea Gore, a professor of pharmacology and toxicology at the University of Texas at Austin ... the harms are clear enough that she advises everyone to try to reduce their exposure, especially parents starting a family and those with young children. "I recommend avoiding added fragrances altogether – in perfumes, scented lotions and shampoos, even scented detergents and antiperspirants," she said.

Note: For more along these lines, read our concise summaries of news articles on health and toxic chemicals.

U.S. government researchers have found that a widely prescribed asthma drug originally sold by Merck & Co, may be linked to serious mental health problems for some patients, according to a scientific presentation reviewed by Reuters. The researchers found that the drug, sold under the brand name Singulair and generically as montelukast, attaches to multiple brain receptors critical to psychiatric functioning. By 2019, thousands of reports of neuropsychiatric episodes, including dozens of suicides, in patients prescribed the drug had piled up on internet forums and in the U.S. Food and Drug Administration's tracking system. Such "adverse event" reports do not prove a causal link between a medicine and a side effect, but are used by the FDA to determine whether more study of a drug's risks are warranted. The reports and new scientific research led the FDA in 2020 to add a "black box" warning to the montelukast prescribing label, flagging serious mental health risks like suicidal thinking or actions. The behavior of montelukast appears similar to other drugs known to have neuropsychiatric effects, such as the antipsychotic risperidone. When the FDA added the black box, it cited research from Julia Marschallinger and Ludwig Aigner. The two scientists told Reuters ... the new data showed significant quantities of montelukast present in the brain. The receptors involved play a role in governing mood, impulse control, cognition and sleep, among other functions, they said.

Note: Reuters reported that the FDA received more than 80 reports of suicides in people taking the medicine. Learn more about how US courts protected Merck from lawsuits regarding Singulair. For more along these lines, explore concise summaries of news articles on mental health and Big Pharma profiteering from reliable major media sources.

Beheadings, mass killings, child abuse, hate speech – all of it ends up in the inboxes of a global army of content moderators. You don't often see or hear from them – but these are the people whose job it is to review and then, when necessary, delete content that either gets reported by other users, or is automatically flagged by tech tools. Moderators are often employed by third-party companies, but they work on content posted directly on to the big social networks including Instagram, TikTok and Facebook. "If you take your phone and then go to TikTok, you will see a lot of activities, dancing, you know, happy things," says Mojez, a former Nairobi-based moderator. "But in the background, I personally was moderating, in the hundreds, horrific and traumatising videos. "I took it upon myself. Let my mental health take the punch so that general users can continue going about their activities on the platform." In 2020, Meta then known as Facebook, agreed to pay a settlement of $52m (Ł40m) to moderators who had developed mental health issues. The legal action was initiated by a former moderator [who] described moderators as the "keepers of souls", because of the amount of footage they see containing the final moments of people's lives. The ex-moderators I spoke to all used the word "trauma" in describing the impact the work had on them. One ... said he found it difficult to interact with his wife and children because of the child abuse he had witnessed. What came across, very powerfully, was the immense pride the moderators had in the roles they had played in protecting the world from online harm.

Note: Read more about the disturbing world of content moderation. For more along these lines, explore concise summaries of revealing news articles on Big Tech from reliable major media sources.

The food system is inextricably linked to an economic system that, for decades, has been fundamentally biased against the kinds of changes we need. Economic policies almost everywhere have systematically promoted ever-larger scale and monocultural production. Those policies include: Massive subsidies for globally traded commodities, direct and hidden subsidies for global transport infrastructures and fossil fuels, ‘free trade' policies that open up food markets in virtually every country to global agribusinesses, [and] health and safety regulations [that] destroy smaller producers and marketers and are not enforced for giant monopolies. Monocultures rely heavily on chemical inputs–fertilizers, herbicides, fungicides, and pesticides–which pollute the immediate environment, put wildlife at risk, and–through nutrient runoff–create "dead zones" in waters ... thousands of miles away. More than half of the world's food varieties have been lost over the past century; in countries like the U.S., the loss is more than 90 percent. Agribusiness has gone to great lengths to convince the public that large-scale industrial food production is the only way to feed the world. But the global food economy is massively inefficient. More than one-third of the global food supply is wasted or lost; for the U.S., the figure is closer to one-half. The solution to these problems ... requires a commitment to local food economies. [Several towns in the state of Maine] declared "food sovereignty" by passing ordinances that give their citizens the right "to produce, process, sell, purchase, and consume local foods of their choosing." In 2013, the government of Ontario, Canada, passed a Local Food Act to increase access to local food, improve local food literacy, and provide tax credits for farmers who donate a portion of their produce to nearby food banks.

Note: Read the full article for a comprehensive explanation of why local food and economies are far better for human health and environment. For more along these lines, explore concise summaries of news articles on food system corruption.

Important Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.